Search

Author/Creator Gandara, David R

1. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Issue 3 (March 2015)

Authors:
Rizvi, Naiyer A; Mazières, Julien; Planchard, David; Stinchcombe, Thomas E; Dy, Grace K; Antonia, Scott J; Horn, Leora; Lena, Hervé; Minenza, Elisa; Mennecier, Bertrand; Otterson, Gregory A; Campos, Luis T; Gandara, David R; Levy, Benjamin P; Nair, Suresh G; Zalcman, Gérard; Wolf, Jürgen; Souquet...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 3(2015:Mar.)
Page Start:
257
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Issue 3 (March 2015)

Authors:
Rizvi, Naiyer A; Mazières, Julien; Planchard, David; Stinchcombe, Thomas E; Dy, Grace K; Antonia, Scott J; Horn, Leora; Lena, Hervé; Minenza, Elisa; Mennecier, Bertrand; Otterson, Gregory A; Campos, Luis T; Gandara, David R; Levy, Benjamin P; Nair, Suresh G; Zalcman, Gérard; Wolf, Jürgen; Souquet...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 3(2015:Mar.)
Page Start:
257
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial. Issue 12 (December 2017)

Authors:
Wakelee, Heather A; Dahlberg, Suzanne E; Keller, Steven M; Tester, William J; Gandara, David R; Graziano, Stephen L; Adjei, Alex A; Leighl, Natasha B; Aisner, Seena C; Rothman, Jan M; Patel, Jyoti D; Sborov, Mark D; McDermott, Sean R; Perez-Soler, Roman; Traynor, Anne M; Butts, Charles; Evans, Tr...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 12(2017:Dec.)
Page Start:
1610
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Issue 10066 (21st January 2017)

Authors:
Rittmeyer, Achim; Barlesi, Fabrice; Waterkamp, Daniel; Park, Keunchil; Ciardiello, Fortunato; von Pawel, Joachim; Gadgeel, Shirish M; Hida, Toyoaki; Kowalski, Dariusz M; Dols, Manuel Cobo; Cortinovis, Diego L; Leach, Joseph; Polikoff, Jonathan; Barrios, Carlos; Kabbinavar, Fairooz; Frontera, Osva...
Journal:
Lancet
Issue:
Volume 389:Issue 10066(2017)
Page Start:
255
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol. Issue 12 (December 2020)

Authors:
Redman, Mary W; Papadimitrakopoulou, Vassiliki A; Minichiello, Katherine; Hirsch, Fred R; Mack, Philip C; Schwartz, Lawrence H; Vokes, Everett; Ramalingam, Suresh; Leighl, Natasha; Bradley, Jeff; Miao, Jieling; Moon, James; Highleyman, Louise; Miwa, Crystal; LeBlanc, Michael L; Malik, Shakun; Mil...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 12(2020)
Page Start:
1589
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study. Issue 1 (January 2018)

Authors:
Herbst, Roy S; Redman, Mary W; Kim, Edward S; Semrad, Thomas J; Bazhenova, Lyudmila; Masters, Gregory; Oettel, Kurt; Guaglianone, Perry; Reynolds, Christopher; Karnad, Anand; Arnold, Susanne M; Varella-Garcia, Marileila; Moon, James; Mack, Philip C; Blanke, Charles D; Hirsch, Fred R; Kelly, Karen...
Journal:
Lancet oncology
Issue:
Volume 19:Issue 1(2018)
Page Start:
101
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I. (10th January 2023)

Authors:
Unger, Joseph M; Qian, Lu; Redman, Mary W; Tavernier, Susan S; Minasian, Lori; Sigal, Ellen V; Papadimitrakopoulou, Vassiliki A; Leblanc, Michael; Cleeland, Charles S; Dzingle, Samuel A; Summers, Thomas J; Chao, Herta; Madhusudhana, Sheshadri; Villaruz, Liza; Crawford, Jeffrey; Gray, Jhanelle E; ...
Journal:
Journal of the National Cancer Institute
Issue:
Volume 115:Number 4(2023)
Page Start:
437
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗